Astrana Health (ASTH) Competitors

Lyft (NASDAQ:LYFT) and Astrana Health (NASDAQ:ASTH) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Which has stronger valuation & earnings, LYFT or ASTH?

Astrana Health has lower revenue, but higher earnings than Lyft. Astrana Health is trading at a lower price-to-earnings ratio than Lyft, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lyft	$5.79B	1.19	$22.78M	$0.24	70.88
Astrana Health	$2.03B	0.85	$43.15M	$0.51	60.16

Does the media favor LYFT or ASTH?

In the previous week, Lyft had 25 more articles in the media than Astrana Health. MarketBeat recorded 29 mentions for Lyft and 4 mentions for Astrana Health. Astrana Health's average media sentiment score of 1.26 beat Lyft's score of 0.76 indicating that Astrana Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lyft	17 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	4 Very Negative mention(s)	Positive
Astrana Health	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is LYFT or ASTH more profitable?

Lyft has a net margin of 1.51% compared to Astrana Health's net margin of 1.04%. Lyft's return on equity of 14.32% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lyft	1.51%	14.32%	1.97%
Astrana Health	1.04%	3.43%	1.87%

Which has more volatility & risk, LYFT or ASTH?

Lyft has a beta of 2.26, suggesting that its share price is 126% more volatile than the S&P 500. Comparatively, Astrana Health has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500.

Do analysts rate LYFT or ASTH?

Lyft currently has a consensus target price of $16.83, suggesting a potential downside of 1.04%. Astrana Health has a consensus target price of $53.29, suggesting a potential upside of 73.68%. Given Astrana Health's stronger consensus rating and higher possible upside, analysts clearly believe Astrana Health is more favorable than Lyft.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lyft	1 Sell rating(s)	20 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.27
Astrana Health	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67

Do insiders and institutionals hold more shares of LYFT or ASTH?

83.1% of Lyft shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 3.1% of Lyft shares are owned by company insiders. Comparatively, 20.0% of Astrana Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Lyft beats Astrana Health on 10 of the 16 factors compared between the two stocks.